Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_843659aad9c4fcabeaa8bd2c0728a181 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10232 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10221 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-80 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-195 |
filingDate |
2016-11-10^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-08-25^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_485a4a3dcbc34ae6cfc8ac2d7e8065f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_857664b5df5ae01e535f6e0c7b027204 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ef71749098f9abb241a683b977cbd92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11e3ca902f57e7d5066747eaac80320e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74c0d989eaff8596b1df34d8ca15e565 |
publicationDate |
2020-08-25^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10751377-B2 |
titleOfInvention |
Vibrio parahaemolyticus bacteriophage Vib-PAP-1 and use thereof for inhibiting proliferation of vibrio parahaemolyticus |
abstract |
The present invention relates to: Podoviridae bacteriophage Vib-PAP-1 (accession number KCTC 12817BP) which has the capability to specifically destroy Vibrio parahaemolyticus , is characterized by having a genome represented by SEQ ID NO: 1, and is isolated from nature; and a method for preventing and treating Vibrio parahaemolyticus infections, using a composition containing bacteriophage Vib-PAP-1 as an active ingredient. |
priorityDate |
2015-12-21^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |